Riordan Clinic Inc

Nonprofit profile at a glance

EIN
480840415
IRS 990 coverage
2013–2024
Forms available
Form 990 2024
Location
Wichita, KS, USA
Phone
3166823100
Rating
70
Verdict
SUPPORTED
Rating confidence
Moderate

Official website

Reported finances

Revenue
$6,735,681
Expenses
$6,209,562
Assets
$3,777,043
Liabilities
$1,190,101

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

4 people listed

Executive titles in this filing

  • MICHAEL STEWART (CEO)

Highest reported compensation

  • RON HUNNINGHAKE (SECRETARY): $183,000 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

To provide medical research and education and to serve in ways that stimulates an epidemic of health among those interested in improving their well-being.

What it reported doing in 2024

Research: at the heart of the riordan clinic's day-to-day work and long-term vision is the riordan clinic research institute. Consisting of a small but dedicated group of scientists who are passionate about their work, the riordan clinic research institute focuses research in areas of nutritional medicine and natural therapeutics. Because of the close relationship between our research team and the physicians at the riordan clinic, we are able to target our research toward innovations that will be directly beneficial to riordan clinic patients. The rcri operates independently of special interests: it neither solicits nor accepts tax-derived funds. All of its research funding comes from private donations from individuals, corporations, and foundations. Results of the rcri's research are presented during lectures and at the conferences, published in peer- reviewed journals, and described on the clinics's website. The riordan clinic research institute works to develop nutrient-based therapies that resolve pathology without harming normal tissues. We have long been a leader in research concerning the use of vitamin c in cancer therapy, and have extensive experience in developing alternative therapies for cancer. Our research in 2022 focused on the following areas (a more in depth report is available by request): -effects of micronutrient supplementation on concentrations of vitamins and minerals, inflammation and cardiovascular risk. -effect of high dose vitamin c on epstein-barr viral infection. -the riordan clinic intravenous vitamin c protocol and background research. -the role of mitochondria in cancer and other chronic diseases. Bioenergetics of human cancer cells and normal cells during proliferation and differentiation. -modulation of cytokines in cancer patients by intravenous ascorbate therapy. -bacterial extracts: biological response modifiers based on bacterial cell wall carbohydrates. Clinic: at riordan clinic, we work with you, as a co-learner, to restore, improve, or maintain your health. We believe in real health, and by understanding your individual biochemical make-up we are able to create a unique health path for you. We focus on nutrition through nutrient testing and we are dedicated to research. Through testing, therapies, services and nutrients we will individualize a journey to ensure that you feel your absolute best. The riordan clinic has cared for individuals with a focus on health, rather than sickness. We believe in the importance of looking at the root cause of illness, rather than treating symptoms. We successfully treat a wide variety of sustained illnesses including, but not limited to: cancer, heart disease, chronic fatigue syndrome, fibromyalgia, and diabetes. Some of our most encouraging success stories are with patients who have a variety of long-term symptoms, but have been unable to get a diagnosis. We seek to identify the underlying causes of illness and correct them using nutrient balancing and other therapies. Symptoms like fatigue, rash, constipation, stiffness, swelling, depression, and many others, are the manifestation of an unbalanced chemistry within the body. At the riordan clinic, we know that the nutrients in our body control our chemistry, and if our inventory is low or in excess of some nutrients, symptoms are inevitable. For this reason, our patients, called co-learners, start with a baseline nutrient inventory panel ordered so that the doctors can learn more about their individuality. Our approach is to treat the whole person, beginning with a thorough review of medical history and a comprehensive patient evaluation. This yields a highly customized holistic treatment plan that will put you on the path to better health. As a patient at the riordan clinic, you will be fully involved in the discovery process of getting well. By taking an active role in your recovery, you will understand the systemic causes of your illness better, thus enacting a positive impact on your health.

Operating model

Revenue model
Earned-program. 81% of the money available for current operations came from fees and other program revenue.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. Some filing-based governance responses are negative or unanswered and total assets are small relative to annual expenses; liquid coverage is unknown.

Rating breakdown

  • Financial Efficiency: 74
  • Transparency & Controls: 70
  • Accountability: 65
  • Sustainability: 46
  • Growth: 80

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 83.9%; rating input score 84
  • Program expense ratio: 83.3%; rating input score 83
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: 1 of 6 controls in place; rating input score 17
    • Compensation committee: Missing
    • Independent consultant: Missing
    • Other Form 990s reviewed: Missing
    • Written employment contract: Missing
    • Compensation survey or study: Missing
    • Board or committee approval: Pass
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 66.7%; rating input score 67; 11th percentile among comparable filings
  • Governance controls: 5 of 8 controls in place; rating input score 62
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: Pass
    • Form 990 shared with the board: Fail
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: 7.8%; rating input score 58; 58th percentile among comparable filings
  • Total-asset coverage ratio: 0.61; rating input score 22; 22nd percentile among comparable filings
  • Liabilities to assets ratio: 0.32; rating input score 33; 33rd percentile among comparable filings
  • Officer compensation ratio: 2.9%; rating input score 69; 69th percentile among comparable filings

Growth

  • Program expense growth: 8.1% per year; rating input score 100; 56th percentile among comparable filings
  • Revenue growth: 6.7% per year; rating input score 100; 53rd percentile among comparable filings
  • Asset growth: -0% per year; rating input score 0; 12th percentile among comparable filings

Details

  • Where the money goes: 83.9% of revenue deployed · 83.3% of spending went to programs
  • Governance: 2 of 3 board members independent · 5 of 8 filing controls reported
  • Programs: 3 filed program accomplishments · $5.2M in reported program spending
  • Leadership: top reported pay $183K · 4 people listed · 1 of 6 pay-setting controls reported
  • Consistency: 32 of 32 current checks pass
  • Schedules: 5 filed schedules · includes major donors and executive pay
  • Filing history: 11 filing years from 2013 to 2024
  • Contacts: How to reach this organization
  • Money network: 1 filed money-flow record
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Review — Accountability: Governance controls: 3 of 8 not reported.
  • High — Sustainability: Total-asset coverage ratio scored 22/100.
  • High — Growth: Asset growth scored 0/100.
  • Review — Sustainability: Operating margin scored 58/100.
  • Moderate — Sustainability: Liabilities to assets ratio scored 33/100.